To assess the efficacy of intranasal corticosteroid therapy in the treatment of obstructive sleep apnea (OSA) based on current evidence.
Methods
A number of medical literature data bases: PubMed, Cochrane Library, Scopus, and CINAHL, were searched comprehensively to identify randomized controlled trials (RCT) that reported on the efficacy of intranasal corticosteroid therapy for OSA. The selected studies were subjected to a meta-analysis and a risk-of-bias assessment.
Results
Seven RCTs met our eligibility criteria, five of these were included in our meta-analysis. The results indicated that intranasal corticosteroid therapy has a better effect in decreasing the apnea-hypopnea index compared with those participants who received placebo (standard mean difference 0.95 [95% confidence interval, -1.42 to -0.47]) (n = 221, I2 = 62%).
Conclusion
Our study results showed that patients who received intranasal corticosteroid therapy had a significant improvement in OSA. However, this evidence was limited by the potential risk of bias and heterogeneity of the selected RCTs.
Get full access to this article
View all access options for this article.
References
1.
EpsteinL.J.KristoD.StrolloP.J.Jr.. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.J Clin Sleep Med5: 263–276, 2009.
2.
RosenC.L.Storfer-IsserA.TaylorH.G.Increased behavioral morbidity in school-aged children with sleep-disordered breathing.Pediatrics114: 1640–1648, 2004.
3.
RedlineS.TishlerP.V.SchluchterM.Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems.Am J Respir Crit Care Med159: 1527–1532, 1999.
4.
MarinJ.M.CarrizoS.J.VicenteE. and AgustiA.G.Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study.Lancet365: 1046–1053, 2005.
5.
GottliebD.J.YenokyanG.NewmanA.B.Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The sleep heart health study.Circulation122: 352–360, 2010.
6.
Martinez-GarciaM.A.Campos-RodriguezF.Catalan-SerraP.Cardiovascular mortality in obstructive sleep apnea in the elderly: Role of long-term continuous positive airway pressure treatment: A prospective observational study.Am J Respir Crit Care Med186: 909–916, 2012.
7.
YamakawaH.ShiomiT.SasanabeR.Pulmonary hypertension in patients with severe obstructive sleep apnea.Psychiatry Clin Neurosci56: 311–312, 2002.
8.
MehraR.BenjaminE.J.ShaharE.Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study.Am J Respir Crit Care Med173: 910–916, 2006.
9.
TanigawaT.YamagishiK.SakuraiS.Arterial oxygen desaturation during sleep and atrial fibrillation.Heart92: 1854–1855, 2006.
10.
MonahanK.Storfer-IsserA.MehraR.Triggering of nocturnal arrhythmias by sleep-disordered breathing events.J Am Coll Cardiol54: 1797–1804, 2009.
11.
CeredaC.W.TamisierR.ManconiM.Endothelial dysfunction and arterial stiffness in ischemic stroke: The role of sleep-disordered breathing.Stroke44: 1175–1178, 2013.
12.
Cardiorespiratory sleep studies in children.Establishment of normative data and polysomnographic predictors of morbidity. American Thoracic Society.Am J Respir Crit Care Med160: 1381–1387, 1999.
13.
MuliolJ.MaurerM. and BousquetJ.Sleep and allergic rhinitis.J Investig Allergol Clin Immunol18: 415–419, 2008.
14.
WeinerJ.M.AbramsonM.J. and PuyR.M.Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials.BMJ317: 1624–1629, 1998.
15.
van BavelJ.FindlayS.R.HampelF.C.Jr.. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis.Arch Intern Med154: 2699–2704, 1994.
16.
KaszubaS.M.BaroodyF.M.deTineoM.Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis.Arch Intern Med161: 2581–2587, 2001.
17.
RakS.HeinrichC.JacobsenL.A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.J Allergy Clin Immunol108: 921–928, 2001.
18.
PulleritsT.PraksL.RistiojaV. and LotvallJ.Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.J Allergy Clin Immunol109: 949–955, 2002.
19.
MeenE.K. and ChandraR.K.The role of the nose in sleep-disordered breathing.Am J Rhinol Allergy27: 213–220, 2013.
20.
HigginsJ.P.T.GreenS.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration http://handbook.cochrane.org/, 2011.
21.
BrouilletteR.T.ManoukianJ.J.DucharmeF.M.Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea.J Pediatr138: 838–844, 2001.
22.
Kheirandish-GozalL. and GozalD.Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome.Pediatrics122: e149–e155, 2008.
23.
AcarM.CingiC.SakalliogluO.The effects of mometasone furoate and desloratadine in obstructive sleep apnea syndrome patients with allergic rhinitis.Am J Rhinol Allergy27: e113–e116, 2013.
24.
EsteitieR.EmaniJ.SharmaS.Effect of fluticasone furoate on interleukin 6 secretion from adenoid tissues in children with obstructive sleep apnea.Arch Otolaryngol Head Neck Surg137: 576–582, 2011.
25.
KielyJ.L.NolanP. and McNicholasW.T.Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis.Thorax59: 50–55, 2004.
26.
MeltzerE.O.MunafoD.A.ChungW.Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep.Ann Allergy Asthma Immunol105: 65–74, 2010.
27.
ChanC.C.AuC.T.LamH.S.Intranasal corticosteroids for mild childhood obstructive sleep apnea: A randomized, placebo-controlled study.Sleep Med16: 358–363, 2015.
28.
BrozekJ.L.BousquetJ.Baena-CagnaniC.E.Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.J Allergy Clin Immunol126: 466–476, 2010.
29.
ChadhaN.K.ZhangL.Mendoza-SassiR.A. and CesarJ.A.Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: Does it work?Otolaryngol Head Neck Surg140: 139–147, 2009.
30.
GreinerA.N. and MeltzerE.O.Overview of the treatment of allergic rhinitis and nonallergic rhinopathy.Proc Am Thorac Soc8: 121–131, 2011.
31.
MeltzerE.O.The treatment of vasomotor rhinitis with intranasal corticosteroids.World Allergy Organ J2: 166–179, 2009.
32.
KalpakliogluA.F.KavutA.B. and EkiciM.Allergic and nonallergic rhinitis: The threat for obstructive sleep apnea.Ann Allergy Asthma Immunol103: 20–25, 2009.
33.
SeidmanM.D.GurgelR.K.LinS.Y.Clinical practice guideline: Allergic rhinitis.Otolaryngol Head Neck Surg152(suppl.): S1–S43, 2015.
